Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 μg and fluticasone propionate 250 μg: Implications for establishing bioequivalence of inhaled products

Autor: Daley-Yates, Peter T., Parkins, David A., Thomas, Marian J., Gillett, Benjamin, House, Karen W., Ortega, Hector G.
Zdroj: In Clinical Therapeutics 2009 31(2):370-385
Databáze: ScienceDirect
Externí odkaz: